Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-154,951
Closed -$3.5M 62
2019
Q3
$3.5M Buy
154,951
+335
+0.2% +$9.28K 0.21% 52
2019
Q2
$5.57M Sell
154,616
-67,047
-30% -$2.15M 0.3% 43
2019
Q1
$6.99M Sell
221,663
-106,040
-32% -$3.09M 0.48% 37
2018
Q4
$8.24M Sell
327,703
-30,063
-8% -$772K 0.76% 30
2018
Q3
$10.3M Sell
357,766
-406,766
-53% -$7.61M 0.62% 29
2018
Q2
$9.36M Buy
764,532
+203,932
+36% +$2.34M 0.67% 24
2018
Q1
$4.47M Buy
+560,600
New +$3.46M 0.43% 31

Other funds holding CDNA

RTW Investments's CDNA Position: Q4 2019 in Review

RTW Investments sold out of CareDx (CDNA) in Q4 2019, closing a stake of 154,951 shares — an estimated $3.5M sold.

RTW Investments first reported a position in CDNA in Q1 2018 and held it in 7 quarters. The position peaked at $10.3M in Q3 2018. 159 funds tracked by Wall St. Rank hold CDNA as of Q4 2019.

  • RTW Investments reported no remaining CareDx position as of Q4 2019 after selling out during the quarter.
  • RTW Investments sold 154,951 CareDx shares in Q4 2019, an estimated $3.5M.
  • RTW Investments first reported a position in CareDx in Q1 2018 and held it in 7 quarters.
  • RTW Investments's CareDx position peaked at $10.3M in Q3 2018.
  • 159 funds tracked by Wall St. Rank held CareDx as of Q4 2019.

Based on RTW Investments's 13F filing for Q4 2019, filed 14 Feb 2020.